Marshall S. Stanton

CIK 1849615 · SVP, Clinical & MD Affair · last filed 2026-03-04

Marshall S. Stanton is a SVP, Clinical & MD Affair who has filed 40 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for AORT, was dated Mar 4, 2026. Across all open-market trades the lifetime net is −$6.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$1.93M

Companies

2

Total Filings

40

Lifetime Open-Market Net

-$6.17M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
AORT	SVP, Clinical & MD Affair	62,246	$28.33	$1.76M	-$6.17M	27	2026-03-04
CRY	SVP, Clinical & MD Affair	9,511	$17.59	$167.3K	$0	1	2021-03-18

Recent Filings

40 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-03-04	AORT	Mixed	+19,689	-$81.2K	EDGAR
2026-03-03	AORT	Notice (144)	−2,149	-$81.2K	EDGAR
2026-03-03	AORT	Sell (S)	−1,513	-$57.5K	EDGAR
2026-03-02	AORT	Notice (144)	−1,513	-$57.5K	EDGAR
2026-02-25	AORT	Sell (S)	−3,682	-$136.0K	EDGAR
2026-02-24	AORT	Notice (144)	−1,259	-$44.9K	EDGAR
2026-02-23	AORT	Notice (144)	−2,423	-$91.1K	EDGAR
2025-11-24	AORT	Mixed	—	-$1.46M	EDGAR
2025-11-24	AORT	Mixed	−11,888	-$622.4K	EDGAR
2025-11-21	AORT	Notice (144)	−47,376	-$2.13M	EDGAR

Showing 1–10 of 40

Page 1 of 4 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.